Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 05, 2019
Metrics Contract Services has announced Troy Woelfel has joined the company as Vice President of Operations and General Manager of Mayne Pharma Greenville Operations.
read more
Friday, February 01, 2013
Metrics Inc. has appointed Joe Cascone as senior director of operations.
In his new role at Metrics, Cascone will manage the company’s commercial drug product manufacturing and packaging capabilities. He also is responsible for facility-related ...
read more
Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, welcomes Anshul Gupte, PhD as Senior Director, Scientific and Technical Affairs. In that capacity, Anshul will be responsible for technical...
read more
Metrics Inc. now has the ability to produce non-sterile liquids, creams and gels for a broad range of pharmaceutical applications.
The company’s scientists stand prepared to manage the formulation development of new products or the technology ...
read more
Wednesday, February 13, 2019
Fresenius Kabi announced the immediate availability in the United States of Methocarbamol Injection, USP in a 100 mg per mL 10 mL vial presentation.
read more
Metabolon, Inc. has entered into an agreement with InnVentis Ltd. to apply metabolomics in individuals with chronic inflammatory diseases, such as rheumatoid arthritis. InnVentis aims to bring together multi-omics technologies with clinical data and ...
read more
Metabolon now offers more than 150 qualified and/or validated targeted biochemical assays for pharmaceutical and biotechnology R&D.
read more
metabion has increased its global production capacity for diagnostic and newly introduced therapeutic oligonucleotides and derivatives thereof to support the rising demand in Europe and worldwide.
read more
Meso Scale Diagnostics has received 510(k) clearance from the FDA for its conventional CRP assay for IVD use in the United States.
read more
ProBioGen AG and Merus N.V. jointly announced that Merus has signed a commercial multi-product license agreement for ProBioGen’s GlymaxX® ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) enhancement technology.
read more
Wednesday, February 03, 2016
Mersana Therapeutics and Takeda Pharmaceutical Company have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada.
read more
Thursday, September 20, 2018
Merrimack Pharmaceuticals has received a $5 million milestone payment from Shire, triggered by the sale of Onivyde in the first major non-European, non-Asian country.
read more
Wednesday, April 12, 2023
Meridian Medical Technologies, a Kindeva Drug Delivery Company, a global CDMO focused on drug-device combination products, announced it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next ...
read more
INC Research Holdings and inVentiv Health announced their Boards of Directors have approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock transaction.
read more
Wednesday, January 05, 2022
Dipharma Francis, a global CDMO and a manufacturer of APIs and intermediates for generic and contract manufacturing markets, is announced that Kalexsyn, Inc., a Michigan corporation acquired in 2018, has been merged into its 100% owner, Dipharma Inc....
read more